Fair Access to Agriculture Disaster Programs Act

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR879 — Medicare Patient Access and Practice Stabilization Act of 2025

Temporarily boosts Medicare payments to physicians and other practitioners by 6.62% for services furnished on or after April 1, 2025 and before January 1, 2026. It also updates statute language so 2025 is included in the program’s payment‑update rules. - Physicians and other practitioners: Receives a temporary 6.62% increase to Medicare payments for covered services during the specified period. - Statutory alignment: Replaces listed years with the range "2021 through 2025" so the 2025 period is applied consistently in the law.

HR909 — Crime Victims Fund Stabilization Act of 2025

Would make the False Claims Act apply to deposits to the Crime Victims Fund through FY2029. It would also require an Inspector General audit that sets the audit's scope, timing, and recipients, and the measure is titled the Crime Victims Fund Stabilization Act of 2025. - Entities that make deposits to the Crime Victims Fund would be subject to the False Claims Act (31 U.S.C. 3729–3731) for deposits from enactment through FY2029. - An Inspector General audit would examine the Crime Victims Fund and the bill would set the audit's scope, timing, and who receives the report.

HR2853 — Combating Organized Retail Crime Act of 2025

This bill creates a centralized Organized Retail and Supply Chain Crime Coordination Center to unify federal, state, local, Tribal, and private-sector efforts. It also strengthens federal criminal tools by expanding forfeiture predicates, adding covered financial instruments, and setting $5,000 aggregate thresholds for certain stolen-goods offenses. - Retailers and supply-chain businesses get a federal hub for intelligence sharing and loss-prevention help. The bill cites a 93% rise in larceny incidents and a 90% rise in average dollar loss from 2019 to 2023. - Prosecutors and investigators gain broader forfeiture and money-laundering authority by adding sections 659, 2314, and 2315 as predicate offenses and by including money orders, general-use prepaid cards, gift certificates, and store gift cards as covered instruments. It also adds a $5,000 aggregate value threshold to those stolen-goods crimes. - The Department of Homeland Security must stand up the Center within 90 days and staff it with federal and state detailees. The law requires evaluations and follow-up reports on grant and training needs and sunsets the Center after 7 years.

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.

HR2102 — Major Richard Star Act

Establishes concurrent receipt for retirees with combat-related disabilities. This bill would let eligible retirees receive both military retired pay and veterans' disability compensation for the same months without the offset rules that currently reduce payments. - Families of disabled retirees: Veterans with combat-related disabilities would receive both retired pay and VA disability compensation for the same months, increasing their monthly household income. - Defense and VA payment rules: The bill would amend 10 U.S.C. 1413a and 10 U.S.C. 1414 to exempt retired pay from reductions under 38 U.S.C. 5304 and 5305 and add a clear monthly no-offset rule. - Implementation and technical changes: It renames and updates chapter sections, adjusts cross-references, and applies to payments beginning the first month after enactment.